National Research Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At present, National Research's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Liabilities is expected to grow to about 106.3 M, whereas Total Assets are forecasted to decline to about 82.7 M. Key indicators impacting National Research's financial strength include:
The essential information of the day-to-day investment outlook for National Research includes many different criteria found on its balance sheet. An individual investor should monitor National Research's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in National Research.
Please note, the presentation of National Research's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National Research's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National Research's management manipulating its earnings.
National Research Stock Summary
National Research competes with Omega Flex, NI Holdings, PC Connection, and Northrim BanCorp. National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. National Research operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 511 people.
Comparative valuation techniques use various fundamental indicators to help in determining National Research's current stock value. Our valuation model uses many indicators to compare National Research value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Research competition to find correlations between indicators driving National Research's intrinsic value. More Info.
National Research Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for National Research Corp is roughly 3.57 . At present, National Research's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Research's earnings, one of the primary drivers of an investment's value.
National Research Corp Systematic Risk
National Research's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. National Research volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on National Research Corp correlated with the market. If Beta is less than 0 National Research generally moves in the opposite direction as compared to the market. If National Research Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one National Research Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of National Research is generally in the same direction as the market. If Beta > 1 National Research moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in National Research Stock are looking for potential investment opportunities by analyzing not only static indicators but also various National Research's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of National Research growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(1.06)
At present, National Research's Price Earnings To Growth Ratio is projected to drop based on the last few years of reporting.
National Research March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of National Research help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of National Research Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of National Research Corp based on widely used predictive technical indicators. In general, we focus on analyzing National Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build National Research's daily price indicators and compare them against related drivers.
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.